Literature DB >> 25030021

Noninvasive detection of a balanced fetal translocation from maternal plasma.

Taylor J Jensen1, Sung K Kim1, Dirk van den Boom2, Cosmin Deciu1, Mathias Ehrich3.   

Abstract

BACKGROUND: Massively parallel sequencing of circulating cell free (ccf) DNA from maternal plasma has been demonstrated to be a powerful method for the detection of fetal copy number variations (CNVs). Although the detection of CNVs has been described by multiple independent groups, genomic aberrations resulting in copy number-neutral events including balanced translocations have proven to be more challenging to detect noninvasively from ccf DNA.
METHODS: Data modeling was initially performed to evaluate multiple methods, ultimately leveraging the short length of ccf DNA and paired-end sequencing to construct read-specific mapping characteristics. After testing in a model system, we evaluated the methods on ccf DNA isolated from the plasma of a donor known to be carrying a fetus with a balanced translocation [t(8;11)]. Sequencing was performed with Illumina sequencing technology.
RESULTS: Our methodology identified the known translocation (P = 1.21 × 10(-8)) and discounted the likelihood of others, enabling the base specific identification of the rearrangement positions. In total, 402 unique sequencing reads spanned the putative breakpoints, of which 76 contained the structural rearrangement. In addition, 38 of the chimeric reads were mapped to each of the resulting derivative chromosomes, supporting the presence of a reciprocal translocation. Finally, we identified a 6-bp deletion present within der(8) that was absent from the der(11) reciprocal rearrangement.
CONCLUSIONS: We have developed an algorithm to detect balanced rearrangements and applied our methodology to demonstrate the first proof-of-principle study on the noninvasive detection of a fetal-specific balanced translocation by sequencing ccf DNA from maternal plasma.
© 2014 American Association for Clinical Chemistry.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25030021     DOI: 10.1373/clinchem.2014.223198

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Lower detectability of non-invasive prenatal testing compared to prenatal diagnosis in high-risk pregnant women.

Authors:  Jing Wang; Zhi-Wei Wang; Qin Zhou; Bin Zhang; Ting Yin; Bin Yu; Lei-Lei Wang
Journal:  Ann Transl Med       Date:  2019-07

2.  Prenatal Diagnosis of Rare Familial Unbalanced Translocation of Chromosomes 7 and 12.

Authors:  Berrin Tezcan; Foteini Emmanouella Bredaki
Journal:  Case Rep Obstet Gynecol       Date:  2015-07-30

3.  Analyzing the most frequent disease loci in targeted patient categories optimizes disease gene identification and test accuracy worldwide.

Authors:  Roger V Lebo; Vijay S Tonk
Journal:  J Transl Med       Date:  2015-01-21       Impact factor: 5.531

4.  Using massively parallel shotgun sequencing of maternal plasmatic cell-free DNA for cytomegalovirus DNA detection during pregnancy: a proof of concept study.

Authors:  Virginie Chesnais; Alban Ott; Emmanuel Chaplais; Samuel Gabillard; Diego Pallares; Christelle Vauloup-Fellous; Alexandra Benachi; Jean-Marc Costa; Eric Ginoux
Journal:  Sci Rep       Date:  2018-03-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.